HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

12th Edition of International Conference on Dentistry
and Oral Health

September 28-30 | London, UK

September 28-30, 2026 | London, UK
ICDO 2026

Effect of antibiotics on oral respiratory microbes

Zvi G Loewy, Speaker at Oral Health Conferences
New York Medical College, United States
Title: Effect of antibiotics on oral respiratory microbes

Abstract:

Innovative medical devices have enhanced health care and improved the overall quality of life. Although providing significant medical benefits, there are unfortunately a myriad of diseases that can be attributed to the presence of medical devices. Microbes can colonize on a medical device surface and cause infections, and at times can even lead to malfunction of the device. Microbial species are present either as planktonic cells or incorporated into biofilms. While different types of medical devices harbor microbes, dental prostheses are some of the most pervasive. The majority of the oral microbes are commensal organisms. Those that are pathogenic microbes can result in oral infections, and at times initiate systemic diseases. Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death world-wide. COPD manifests as an inflammatory condition involving the airways, lung parenchyma and pulmonary vasculature. COPD exacerbation correlates with bacterial colonization of the upper and lower airways. Key bacteria implicated in COPD and resident initially in the oral cavity are Pseudomonas aeruginosa, Haemophilus influenzae and Moraxella catarrhalis. In this study we focus on characterizing the activity of antibiotics on oral-respiratory microbes both in planktonic form as well as biofilms.

Biography:

Dr. Zvi Loewy is a senior academic leader and an experienced global pharmaceutical – biotechnology executive. He leverages a diversified background in big-pharma senior management, biotech startup creation and academia. Dr. Loewy has served as a board member of the New Jersey Bioscience Center Incubator since 2010. Dr. Loewy’s international experience has included leading international research teams, championing the penetration and commercial launch of healthcare products world-wide, and leading open innovation in the Mid-East. Dr. Loewy received his PhD in Molecular Biology from the Albert Einstein College of Medicine. Dr. Loewy has over 25 issued patients.

Watsapp